登录

MicroMedTec Announces ¥100M Series A Financing

作者: Mailman 2021-02-26 14:59
微密医疗
http://www.micromedtec.com/
企业数据由 动脉橙 提供支持
微创介入治疗设备研发商 | A轮 | 运营中
中国-上海
2021-02-22
融资金额:RMB¥1亿
高瓴创投
查看

(VCBeat) Feb. 22, 2021 -- Shanghai Micro Medical Technology Co., Ltd. ("MicroMedTec"), which focuses on the R&D of innovative neurointerventional devices, today announced closing a Series A financing round of over 100 million yuan. The latest round was led by GL Ventures with participation from Jisu Capital and Zhongxin Innovation Capital. The investment will enable MicroMedTec to accelerate the further development of neurointerventional products and promote the clinical trials and registration of "MeshCoil", the first vascular plug for aneurysm in China.


Previously, MicroMedTec received investments in the angel round in November 2018, and tens of millions of yuan in the Pre-A round from Chende Capital in January 2020.


MicroMedTec is a medical equipment company that develops interventional treatment products for cerebrovascular diseases. The company focuses on minimally invasive treatments and is committed to providing new solutions for cerebrovascular patients. At present, it has developed "MeshCoil" for minimally invasive interventional therapy of intracranial hemorrhagic aneurysms.


MicroMedTec's self-developed "MeshCoil" has entered the registration of clinical trials and the studies are going to be conducted in 10 hospitals, including Beijing Xuanwu Hospital. The company also has several innovative neurointerventional devices in various stages of development.


>>>>

About GL Ventures


GL Ventures was set up by private equity heavyweight Hillhouse Capital to invest in emerging startups in February 2020. GL Ventures focuses on four areas: biomedicine and medical devices, software services and initiatives in tech innovations, consumer internet and technology, and emerging consumer brands and services.


>>>>

About Jisu Capital


Jisu Capital, founded in 2016, is a venture capital firm focusing on the domestic healthcare industry in China. With the guidance of "love innovation and create value", the company has invested in such excellent enterprises as Venus Medtech,Broncus, Valgen Medtech, and so on. In the future, Jisu Capital will continue to focus and look forward to creating value for more portfolios and growing together with entrepreneurs.

相关赛道 其它耗材
注:文中如果涉及企业数据,均由受访者向分析师提供并确认。
声明:动脉网所刊载内容之知识产权为动脉网及相关权利人专属所有或持有。转载请联系tg@vcbeat.net。

Mailman

医疗行业观察者

分享
动脉橙
以上数据来自动脉橙产业智库

我们以独创的在线数据库方式,为健康产业人士提供全方位和实时的市场资讯、行业数据和分析师见解。现已覆盖数字健康、医疗器械、生物医药等近500+细分赛道,涉及公司名单、招投标、投融资信息、头部企业动态等各类数据并持续更新。

点击 【申请试用】了解动脉橙产业智库更多内容。
精彩内容推荐

【首发】国内生物磁设备龙头厂商漫迪医疗完成近亿元A+轮融资

【首发】垦拓流体完成超亿元C轮融资,破解精密微流体控制元件卡脖子难题

【首发】睿触科技完成华登国际千万级美元A+轮次融资,打造国际领先的手术机器人平台公司

Yi Chao Medical Announces ¥10M Series A Financing

Mailman

共发表文章3245篇

最近内容
  • 知之甚少:调研885名投资人后,原来美国VC们这样做决策

    2023-03-20

  • 辉瑞想要收购Seagen只是开始,这才是2023年并购的两大趋势

    2023-03-05

  • 【融资】核药企业Ratio再融资2000万美元,和拜耳合作研究新前列腺癌放射性疗法

    2023-02-09

上一篇

Pushkang Secures ¥100 Million in Series C Funding Round

2021-02-26
下一篇

Good Doctor Cloud Health Raises ¥100 Million in Series A Funding Round

2021-02-26